Dr. Benjamin Greenberg answers questions about the currently enrolling Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis. Dr. Greenberg talks about the process of selecting participants, what qualifications must be met, and the timeline of the study. He also answers questions on the risks of participation. Dr. Greenberg explains what participation in the study entails, and what outcomes his team will look at to deem the trial successful. Questions about a possible Phase II of the trial are discussed.
For more information on the study, please visit the study page here.
If you are interested in participating in the study, please fill out this form to start the screening process.